[From Hospitals & Health Networks Daily, September 20, 2011] There is fire in the valley and smoke in the mountains. A plague is on the land and danger is afoot. That may be — maybe — the good news. Health care is more unstable than it has been at any time in...
Traditional drug and device research aims to show whether a drug or device has a some positive effect, and doesn’t kill or hurt any more people than not using it. Comparative effectiveness research (CER), in contrast, compares the drug or device with all...
Cutting costs does not cut costs. If we hope to steer health care toward a better cheaper future, we have to wrap our minds around this conundrum: Slashing spending does not necessarily improve the bottom line. Governments in Ireland and the United Kingdom have come...
Lindsey Dunn of Becker’s ASC Review reports on what I had to say to the Ambulatory Surgeons meeting in Chicago the other day: In a keynote address to attendees at the 9th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference in Chicago on June 10,...
Under the headline, “Medicare Plan for Payments Irks Hospitals,” today’s New York Times details the opposition stirred up by the government’s “value-based purchasing” initiative. If you’re buying anything (and the US federal government is the largest purchaser of...
[Note to the reader: Anything that is in italics and square brackets (such as this note) is addressed to you, personally. Yes, you. Try it on, see if it fits.] Healthcare has, right now, the greatest opportunity we have seen in our lifetimes to make a big change, to...
